Demographic and principal clinical characteristics of patients
Patient no. . | Age, y/sex . | Diagnosis . | Stage . | M comp, g/L . | β-2M, mg/L . | CRP, mg/L . | CD133+ CECs/total CECs (%) . | CECs with 13q14 del/total CECs (%) . | CD133+ CECs with 13q14 del/CECs with 13q14 del (%) . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 63/M | MM IgG/κ | IA | 12.0 | 4.4 | 9.6 | 183/200 (91.5) | 22/200 (11) | 18/18 (100) |
| 2 | 68/F | MM IgA/κ | IIIA | 13.9 | 5.0 | 25.9 | 168/200 (84) | 32/200 (16) | 32/32 (100) |
| 3 | 70/M | MM IgG/λ | IA | 28.0 | 2.7 | 0.4 | 185/200 (92.5) | 26/200 (13) | 20/22 (90.9) |
| 4 | 62/F | MM IgG/κ | IIIA | 12.1 | 3.1 | 0.9 | 158/200 (79) | 36/200 (18) | 36/36 (100) |
| 5 | 44/M | MM IgG/λ | IIIA | 30.1 | 2.5 | 8.9 | 168/200 (84) | 64/200 (32) | 62/64 (96.9) |
| MGUS | |||||||||
| 6 | 49/F | IgG/κ | NA | 12.8 | 1.5 | 0.3 | 16/200 (8) | 6/200 (3) | NA |
| MGUS | |||||||||
| 7 | 47/F | IgG/κ | NA | 11.8 | 1.4 | 1.9 | 18/170 (10.6) | 7/170 (4.1) | NA |
| MGUS | |||||||||
| 8 | 61/F | IgA/κ | NA | 5.7 | 2.1 | 1.5 | 21/155 (13.5) | 6/155 (3.9) | NA |
Patient no. . | Age, y/sex . | Diagnosis . | Stage . | M comp, g/L . | β-2M, mg/L . | CRP, mg/L . | CD133+ CECs/total CECs (%) . | CECs with 13q14 del/total CECs (%) . | CD133+ CECs with 13q14 del/CECs with 13q14 del (%) . |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 63/M | MM IgG/κ | IA | 12.0 | 4.4 | 9.6 | 183/200 (91.5) | 22/200 (11) | 18/18 (100) |
| 2 | 68/F | MM IgA/κ | IIIA | 13.9 | 5.0 | 25.9 | 168/200 (84) | 32/200 (16) | 32/32 (100) |
| 3 | 70/M | MM IgG/λ | IA | 28.0 | 2.7 | 0.4 | 185/200 (92.5) | 26/200 (13) | 20/22 (90.9) |
| 4 | 62/F | MM IgG/κ | IIIA | 12.1 | 3.1 | 0.9 | 158/200 (79) | 36/200 (18) | 36/36 (100) |
| 5 | 44/M | MM IgG/λ | IIIA | 30.1 | 2.5 | 8.9 | 168/200 (84) | 64/200 (32) | 62/64 (96.9) |
| MGUS | |||||||||
| 6 | 49/F | IgG/κ | NA | 12.8 | 1.5 | 0.3 | 16/200 (8) | 6/200 (3) | NA |
| MGUS | |||||||||
| 7 | 47/F | IgG/κ | NA | 11.8 | 1.4 | 1.9 | 18/170 (10.6) | 7/170 (4.1) | NA |
| MGUS | |||||||||
| 8 | 61/F | IgA/κ | NA | 5.7 | 2.1 | 1.5 | 21/155 (13.5) | 6/155 (3.9) | NA |
M comp indicates M component; β-2M, β2-microglobulin; CRP, C-reactive protein; and NA, not applicable.